UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Clinical infectious diseases, ISSN 1058-4838, 11/2019, Volume 69, Issue 10, pp. 1690 - 1700
Journal Article
Annals of clinical microbiology and antimicrobials, ISSN 1476-0711, 10/2019, Volume 18, Issue 1, pp. 30 - 30
Bloodstream infection | Endocarditis | Dalbavancin | Life Sciences & Biomedicine | Microbiology | Science & Technology | Length of Stay | Endocarditis, Bacterial - drug therapy | Humans | Middle Aged | Male | Treatment Outcome | Teicoplanin - therapeutic use | Drug-Related Side Effects and Adverse Reactions - epidemiology | Drug-Related Side Effects and Adverse Reactions - pathology | Teicoplanin - adverse effects | Anti-Bacterial Agents - therapeutic use | Sepsis - drug therapy | Cost-Benefit Analysis | Female | Aged | Anti-Bacterial Agents - adverse effects | Retrospective Studies | Gram-Positive Bacterial Infections - drug therapy | Teicoplanin - analogs & derivatives | Infective endocarditis | Sepsis | Gram-positive bacterial infections | Drug therapy | Patient outcomes | Index Medicus
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 02/2020, Volume 75, Issue 5, pp. 482 - 494
Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Enterococcus faecalis - isolation & purification | Endocarditis, Bacterial - epidemiology | Spain - epidemiology | Humans | Middle Aged | Gram-Positive Bacterial Infections - microbiology | Endocarditis, Bacterial - microbiology | Female | Male | Aged | Cohort Studies | Gram-Positive Bacterial Infections - epidemiology
Journal Article
Clinical infectious diseases, ISSN 1058-4838, 6/2015, Volume 60, Issue 11, pp. 1642 - 1649
ARTICLES AND COMMENTARIES | investigator-driven clinical trial | levofloxacin | tenosynovitis | tuberculosis | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Antitubercular Agents - adverse effects | Liver Transplantation | Prospective Studies | Humans | Middle Aged | Antibiotic Prophylaxis - methods | Male | Treatment Outcome | Antibiotic Prophylaxis - adverse effects | Tenosynovitis - chemically induced | Transplant Recipients | Drug-Related Side Effects and Adverse Reactions - epidemiology | Drug-Related Side Effects and Adverse Reactions - pathology | Incidence | Tuberculosis - prevention & control | Tenosynovitis - epidemiology | Antitubercular Agents - administration & dosage | Adult | Female | Aged | Levofloxacin - administration & dosage | Levofloxacin - adverse effects | Levofloxacin | Care and treatment | Usage | Tuberculosis | Tenosynovitis | Clinical trials | Dosage and administration | Risk factors | Transplants & implants | Antibiotics | Liver | Medical treatment | Index Medicus
Journal Article
International journal of cardiology, ISSN 0167-5273, 05/2019, Volume 282, pp. 24 - 30
Heart failure | Mortality | Embolism | Bacteremia | Endocarditis | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Prospective Studies | Survival Rate - trends | Endocarditis, Bacterial - mortality | Humans | Middle Aged | Male | Cardiac Surgical Procedures - mortality | Hospital Mortality - trends | Endocarditis, Bacterial - surgery | Endocarditis - mortality | Female | Aged | Cardiac Surgical Procedures - methods | Endocarditis - surgery | Infective endocarditis | Patient outcomes | Cardiac patients | Index Medicus
Journal Article
Clinical infectious diseases, ISSN 1058-4838, 2/2012, Volume 54, Issue 3, pp. 355 - 361
Heart | Cytomegalovirus | Infectious diseases | Toxoplasmosis | Heart transplantation | Predisposing factors | Hospital units | Transplantation | Infections | Preventive medicine | ARTICLES AND COMMENTARIES | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Parasitic diseases | Protozoal diseases | Biological and medical sciences | Human protozoal diseases | Medical sciences | Humans | Middle Aged | Risk Factors | Anti-Infective Agents - therapeutic use | Male | Toxoplasmosis - etiology | Case-Control Studies | Young Adult | Toxoplasmosis - pathology | Organ Transplantation - adverse effects | Adolescent | Adult | Female | Prednisone - pharmacology | Aged | Care and treatment | Organ transplant recipients | Transplantation of organs, tissues, etc | Health aspects | Methods | Risk factors | Polymerase chain reaction | Regression analysis | Transplants & implants | Mortality | Infection | Brain | Hospitals | Morbidity | Enlargement | Index Medicus
Journal Article
Journal of antimicrobial chemotherapy, ISSN 0305-7453, 06/2019, Volume 74, Issue 6, pp. 1713 - 1717
Journal Article
BMC infectious diseases, ISSN 1471-2334, 10/2012, Volume 12, Issue 1, pp. 245 - 245
Antibiotic empirical treatment | Gram negative | Prognosis | Extended-spectrum β-lactamase | Bacteremia | Life Sciences & Biomedicine | Infectious Diseases | Science & Technology | Escherichia coli Infections - mortality | Humans | Middle Aged | Child, Preschool | Bacteremia - mortality | Infant | Male | Klebsiella - isolation & purification | Bacteremia - microbiology | Young Adult | Anti-Bacterial Agents - therapeutic use | Aged, 80 and over | Adult | Female | Child | Infant, Newborn | Escherichia coli Infections - drug therapy | Escherichia coli - enzymology | Klebsiella Infections - drug therapy | Bacteremia - drug therapy | Escherichia coli Infections - microbiology | Klebsiella - enzymology | Treatment Outcome | Klebsiella Infections - microbiology | beta-Lactamases - secretion | Spain | Escherichia coli - isolation & purification | Adolescent | Survival Analysis | Klebsiella Infections - mortality | Aged | Cohort Studies | Infection | Care and treatment | Medical examination | Antibiotics | Analysis | Mortality | Escherichia coli | Beta lactamases | Health aspects | Blood | Studies | Infections | Index Medicus
Journal Article
Clinical infectious diseases, ISSN 1058-4838, 11/2013, Volume 57, Issue 9, pp. 1225 - 1233
Recommendations | Health outcomes | Infectious diseases | Microbiology | Mortality | Infections | ARTICLES AND COMMENTARIES | Bacteremia | Staphylococcus aureus | Blood | Catheters | bloodstream infections | clinical management | intervention | bacteremia | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Science & Technology | Bacterial diseases | Human bacterial diseases | Staphylococcal infections, streptococcal infections, pneumococcal infections | Biological and medical sciences | Medical sciences | Bacterial sepsis | Staphylococcal Infections - drug therapy | Tertiary Care Centers | Humans | Bacteremia - drug therapy | Bacteremia - mortality | Treatment Outcome | Bacteremia - diagnosis | Spain | Bacteremia - microbiology | Anti-Bacterial Agents - therapeutic use | Staphylococcal Infections - mortality | Staphylococcal Infections - diagnosis | Guideline Adherence | Case Management | Survival Analysis | Medical care | Care and treatment | Research | Staphylococcus aureus infections | Quality management | Staphylococcus infections | Systematic review | Antibiotics | Evidence-based medicine | Medical prognosis | Quality of care | Index Medicus | Indexing in process
Journal Article